Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

ohm, do you have any references for blood/brain ba

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155002
(Total Views: 830)
Posted On: 09/16/2020 8:28:03 PM
Posted By: havasu78
Re: ohm20 #56185
ohm, do you have any references for blood/brain barrier?

My limited reading on antibodies crossing the blood brain barrier is that they don't cross the blood/brain barrier.

Do you have any references that you can share?

I have some doubts as to the basic blood/barrier claims made in today's conference call.

How exactly did they determine that receptor occupancy was 70% inside the monkey brains?

And what cells inside the monkey brain did they test and how did they get them? Are there even enough T-cells present in the CNS to obtain a decent sample?

So I wonder exactly which cells they measured and how did they obtain the cells.

I haven't read much about monoclonal antibodies crossing the blood/brain barrier, but I am familiar with a failed effort by AbbVie and Voyager to deploy monoclonal antibodies to the CNS. About three years ago, AbbVie gave Voyager $150 million upfront to develop monoclonal gene therapy for CNS applications. Voyager, who is experienced in Parkinson's gene therapy delivered directly to the brain, was tasked with developing an AAV viral vector that could deliver a DNA payload. The DNA payload was supposed to form an episome in brain cell nuclei and the express mRNA which would produce monoclonal antibodies.

The AbbVie/Voyager program was a failure because the Voyager AAV viral delivery vector could not be developed.

While the program was a failure, it was illustrative of conventional wisdom on monoclonal antibodies, namely that mabs cannot cross the blood/brain barrier. AbbVie has a big monoclonal antibody business. It seems to me that if AbbVie mabs can cross the blood/brain barrier then no need for the Voyager program.

I have read elsewhere that mabs can't cross the blood brain barrier.

A simple google scholar search "monoclonal antibodies that can cross the blood brain barrier" yields many articles, but they are all tricks to get stuff across. No regular mabs going across.


(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us